Purchase Order 36C26326P0348

Edwards Lifesciences LLC, a leading cardiovascular medical device manufacturer and self-certified small disadvantaged business, has been awarded a $34,000 firm fixed-price purchase order by Veterans Integrated Service Network 23 (Minneapolis, Minnesota) for transcatheter aortic valve replacement (TAVR) systems and related cardiac technologies. The award, issued on March 27, 2026, with an ultimate completion date of April 26, 2026, represents a non-set-aside procurement reflecting Edwards Lifesciences' specialized manufacturing capability for these critical surgical implants. As a subsidiary of Edwards Lifesciences Corporation, the company supplies advanced transcatheter heart valves, including its SAPIEN 3 and SAPIEN 3 Ultra systems with RESILIA tissue technology, to support the Department of Veterans Affairs' cardiac care mission for the veteran population.

This purchase order is consistent with Edwards Lifesciences LLC's extensive contracting relationship with the VA healthcare system, which has generated over 200 prime federal contract awards since 2025, predominantly through firm fixed-price purchase orders across multiple Veterans Integrated Service Networks. The company maintains two Indefinite Delivery Contracts with the VA totaling $7.45 million: a $6.5 million five-year agreement with VISN 21 (Palo Alto) for surgical implant consignment services through December 2030, and a $950,000 five-year contract with VISN 15 for heart valves and cardiovascular devices through October 2030. These frameworks, combined with individual purchase orders typically ranging from $32,500 to $102,000, establish Edwards Lifesciences as the primary supplier of specialized cardiac devices essential to VA surgical programs across multiple service networks.